The FDA’s ongoing efforts to regulate AI-enabled medical devices highlight significant challenges, including regulatory gaps, the need for comprehensive frameworks, and ethical concerns related to bias and safety, as it seeks to ensure the effectiveness of these rapidly evolving technologies.
View full story…